Literature DB >> 24290839

Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease.

Stergios A Polyzos1, Christos S Mantzoros2.   

Abstract

Entities:  

Mesh：

Year:  2013        PMID： 24290839     DOI： 10.1016/j.metabol.2013.10.010

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  13 in total

1.  Periostin on the road to nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis
Journal:  Endocrine       Date:  2015-11-19       Impact factor: 3.633

2.  Circulating periostin in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Athanasios D Anastasilakis; Athanasios Papatheodorou; Panagiotis Kokkoris; Evangelos Terpos
Journal:  Endocrine       Date:  2016-10-13       Impact factor: 3.633

3.  Evaluation of Nonalcoholic Fatty Liver Disease in C57BL/6J Mice by Using MRI and Histopathologic Analyses.

Authors:  Jae-Eun Ryu; Woori Jo; Hyun-Ji Choi; Sungwoong Jang; Hyo-Ju Lee; Dong-Cheul Woo; Jeong Kon Kim; Kyung Won Kim; Eun Sil Yu; Woo-Chan Son
Journal:  Comp Med       Date:  2015-10       Impact factor: 0.982

4.  Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Athanasios D Anastasilakis; Jannis Kountouras; Polyzois Makras; Athanasios Papatheodorou; Panagiotis Kokkoris; Grigorios T Sakellariou; Evangelos Terpos
Journal:  J Bone Miner Metab       Date:  2015-06-09       Impact factor: 2.626

Review 5.  Nonalcoholic fatty liver disease: lifestyle and quality of life.

Authors:  Ilias Vachliotis; Antonis Goulas; Paraskevi Papaioannidou; Stergios A Polyzos
Journal:  Hormones (Athens)       Date:  2021-12-01       Impact factor: 2.885

Review 6.  Importance of imaging and recent developments in diagnosis of nonalcoholic fatty liver disease.

Authors:  Mustafa Koplay; Mesut Sivri; Hasan Erdogan; Alaaddin Nayman
Journal:  World J Hepatol       Date:  2015-04-18

7.  Activin A and follistatin in patients with nonalcoholic fatty liver disease.

Authors:  Stergios A Polyzos; Jannis Kountouras; Athanasios D Anastasilakis; Georgios Α Triantafyllou; Christos S Mantzoros
Journal:  Metabolism       Date:  2016-07-25       Impact factor: 8.694

Review 8.  Circulating leptin in non-alcoholic fatty liver disease: a systematic review and meta-analysis.

Authors:  Stergios A Polyzos; Konstantinos N Aronis; Jannis Kountouras; Dimitrios D Raptis; Maria F Vasiloglou; Christos S Mantzoros
Journal:  Diabetologia       Date:  2015-09-26       Impact factor: 10.122

Review 9.  Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis.

Authors:  Yuki Haga; Tatsuo Kanda; Reina Sasaki; Masato Nakamura; Shingo Nakamoto; Osamu Yokosuka
Journal:  World J Gastroenterol       Date:  2015-12-14       Impact factor: 5.742

Review 10.  Imaging Features of Non-Alcoholic Fatty Liver Disease in Children and Adolescents.

Authors:  Michele Di Martino; Kameliya Koryukova; Mario Bezzi; Carlo Catalano
Journal:  Children (Basel)       Date:  2017-08-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.